Researchers who led a new landmark clinical trail using carding MRI found that combining heart medication with chemotherapy reduces the risk of heart damage in patients with early-stage breast cancer.
The new five year study at the University of Alberta and Alberta Health Services found that beta blockers and ACE inhibitors, effectively prevent a drop in heart function from cancer treatment.
The study is funded by the Canadian Institutes of Health Research (CIHR) and Alberta Cancer Foundation.
Read the full article here:
Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.